US · Basic Materials · Specialty Chemicals
EPS came in at 0.05 against a street estimate of 0.20 — a miss of 75.4%.
Analysts rate Chemours Co a buy (5 buy, 5 hold, 0 sell out of 10) with an average price target of $24.67.
| Fund | Stake |
|---|---|
| BlackRock Inc | 14.89% |
| Vanguard Portfolio Management, LLC | 6.87% |
| Vanguard Capital Management, LLC | 4.50% |
| State Street Corp | 4.07% |
| Ameriprise Financial Inc | 3.22% |
| American Century Companies Inc | 2.94% |
| JPMorgan Chase & Co | 2.53% |
| Wolf Hill Capital Management, LP | 2.45% |
| Document | Date |
|---|---|
| Material agreement · Q2 2026 | 2026-06-24 |
| Quarterly report · Q1 2026 | 2026-05-05 |
| Results announced · Q2 2026 | 2026-05-05 |
| Board / officer change · Q2 2026 | 2026-04-30 |
| Material agreement · Q1 2026 | 2026-03-12 |
| Proxy statement · Q2 2026 | 2026-03-10 |
| Annual report FY2025 | 2026-02-24 |
| Quarterly report · Q3 2025 | 2025-11-06 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Chemours Co — free to start.
Google PlayApp StoreData updated 2026-08-05.